Pharmacy sales in Ukraine for the January–September 2026 period rose by 16.7% in monetary terms compared to the same period in 2025—reaching nearly 186.387 billion UAH, while in volume terms, they fell by 5%, to nearly 802.242 million packages, the company “Business Credit” reported to the Interfax-Ukraine news agency, citing a study it conducted.
According to the report, the weighted average price of the pharmacy basket for the period in question was 232.33 UAH per package, which is 22.91% higher than during the same period a year earlier.
At the same time, pharmacy sales of medicines increased by 23.12% in monetary terms—to more than 152.26 billion UAH—and by 6.34% in volume terms—to nearly 634.961 million packages.
The weighted average retail price of pharmaceuticals for the first nine months of 2026 was 239.79 UAH per package, which is 15.79% higher than in January–September 2025.
At the same time, pharmacy sales of dietary supplements in the first nine months of 2026 increased by 7.5% in monetary terms—to nearly 19.764 billion UAH—while in volume terms they decreased by 17.7%—to 59.913 million packages. The weighted average price in this segment rose by 30.72%—to 329.88 UAH per unit.
Business Credit notes that from January through September 2026, the highest price increases in pharmacy retail were seen in products for parenteral administration of medications (syringes, injection needles, infusion sets/drip sets/transfusion sets, catheters—IF-U), which rose in price by 53.47%.
Overall, according to the company’s data, in the pharmacy retail sector over the first nine months of 2026, sales volumes in monetary terms decreased across all product categories except dietary supplements (+7.5%), therapeutic cosmetics (+21.4%), and mineral water (+4.8%).
At the same time, in volume terms, pharmacy sales increased only in the pharmaceuticals category.
As previously reported, pharmacy sales in Ukraine for the period from January through August 2026 increased by 15.7% in monetary terms compared to the same period in 2025—to more than nearly 162 billion UAH—while in volume terms, they decreased by 5.86%, to nearly 707,313 thousand packages. The weighted average price of items in the pharmacy basket for the period was 229.76 UAH per package, which is 22.88% higher than during the same period a year earlier.
At the same time, pharmacy sales of pharmaceuticals increased by 21.32% in monetary terms—to nearly 132.199 billion UAH—and by 5.13% in volume terms—to nearly 556.962 million packages. The weighted average retail price of medicines for the first eight months of 2026 was 237.36 UAH per package, which is 15% higher than in January–August 2025.
For the full year 2025, pharmacy sales in monetary terms increased by 14.23% compared to 2024—to more than 220.287 billion UAH—while in volume terms, they decreased by 2.25%, to nearly 1.135 million packages. The weighted average price of items in the pharmacy basket was 194.68 UAH per package, which is 16.86% higher than a year earlier. Pharmacy sales of medicines in 2025 increased by 12.79% in monetary terms—to nearly 170.318 billion UAH—while in volume terms, they decreased by 0.2% compared to 2024, to 808.546 million packages. The weighted average retail price of pharmaceuticals at the end of 2025 was 210.65 UAH per package, which is 13% higher than at the end of 2024.
The “Podorozhnik” pharmacy chain (Lviv) has topped the ranking of the country’s pharmacy chains by number of locations and sales.
According to the publication “Apteka,” second in the ranking of the largest chains by number of locations is the “Apteka 9-1-1” chain (Kharkiv), which operates under the “9-1-1” and “Apteka Wholesale Prices” brands; in third place is “Apteka-Magnolia” LLC (Zaporizhzhia), known for the brands ANC, “Kopiyka,” “Shara,” and “Blagodiya”; in fourth place is “Sirius-95” LLC (Kyiv), which operates under the “We Wish You Health” brand; in fifth place is “Pharmastor” LLC (Kyiv, “Good Day Pharmacy”).
In terms of sales volume, “Apteka-Magnolia” ranks second in the top 5, third place goes to the “Apteka 9-1-1” chain, and fourth and fifth places are held by “Sirius-95” and “Farmastor” (“Bazhaemo Zdorov’ya” and “Apteka Dobrogo Dnya”).
The publication does not report the number of retail locations, but media outlets cite varying numbers depending on the calculation method.
As the “Podorozhnik” chain clarified to the Interfax-Ukraine news agency, as of the end of August 2026, this pharmacy chain’s turnover reached 3.814 billion UAH, with approximately 2,400 retail locations.
Pharmacy sales of drugs in Ukraine from January through June 2026 increased by 19.52% in monetary terms compared to the same period last year, reaching nearly 97.918 billion UAH.
According to a report by Business Credit to the Interfax-Ukraine news agency, citing research findings, sales of medicines in volume terms also rose—by 4.9%, to nearly 418.711 million packages.
The weighted average retail price of pharmaceuticals for the first half of the year was 233.85 UAH per package, which is 13.96% higher than the figure for January–June 2025.
Thus, the pharmaceutical segment demonstrated growth not only due to higher prices but also thanks to an increase in the number of packages sold. This distinguishes it from the pharmacy market as a whole, where sales in physical terms declined by 5.8% over the six-month period.
In the first quarter of 2026, pharmaceutical sales rose by 13.9% in monetary terms—to over 48.426 billion UAH—and by 4.85% in volume terms—to nearly 211.947 million packages.
In 2025, Ukrainian pharmacies sold medicines worth 170.318 billion UAH, which is 12.79% more than the previous year. The volume of sales then decreased by 0.2% to 808.546 million packages.
Pharmacy sales in Ukraine from January to June 2026 increased by 15% in monetary terms compared to the same period in 2025—reaching nearly 121 billion hryvnia—while in volume terms, they decreased by 5.8%—to approximately 533.955 million packages.
The company “Business Credit” reported this to the Interfax-Ukraine news agency, citing the results of a study it conducted.
The weighted average price of items in the pharmacy basket for the first half of the year was 226.65 UAH per package, which is 22.15% higher than in January–June 2025.
Thus, the growth of the pharmacy market in monetary terms occurred against the backdrop of a decline in the total number of packages sold and a significant increase in the average cost of pharmacy products.
At the same time, the market’s growth rate in monetary terms accelerated compared to the first quarter. In January–March, pharmacy sales increased by 11.13%—to 60.245 billion UAH—while the volume of sales decreased by 4.8%, to approximately 270.958 million packages.
At the end of 2025, pharmacy sales in Ukraine totaled over 220.287 billion UAH, which is 14.23% more than in 2024. In volume terms, they declined by 2.25% during that period.
Pharmacy sales in Ukraine for the January–March 2025 period rose by 11.13% in monetary terms compared to the same period in 2025—to more than 60.245 billion UAH, while in volume terms they decreased by 4.8%—to nearly 270,958 thousand packages, the company “Business Credit” reported to the agency “Interfax-Ukraine,” citing data from a study.
According to the data, the weighted average price of the pharmacy basket of goods for January–March 2026 was 222.34 UAH per package, which is 16.78% higher than during the same period a year earlier.
At the same time, pharmacy sales of medicines during this period increased by 13.9% in monetary terms—to more than 48.426 billion UAH—and by 4.85% in volume terms compared to the same period in 2025, reaching nearly 211.947 million packages.
The weighted average retail price of medicines for the first two months of 2026 was 228.49 UAH per package, which is 8.63% higher than in January–March 2025.
At the same time, pharmacy sales of dietary supplements in the first three months of 2026 increased by 14.5% in monetary terms—to nearly 7.03 billion UAH—while sales in volume terms decreased by 14.97%, to 22.378 million packages. The weighted average price in this segment rose by 34.7%—to 314.13 UAH per unit.
As reported, pharmacy sales in Ukraine for 2025 increased by 14.23% in monetary terms compared to 2024—to more than UAH 220.287 billion, while in volume terms they decreased by 2.25%—to nearly 1.135 million packages. The weighted average price of items in the pharmacy basket at the end of 2025 was 194.68 UAH per package, which is 16.86% higher than a year earlier.
At the same time, pharmacy sales of medicines during this period increased by 12.79% in monetary terms—to nearly UAH 170.318 billion—while in volume terms, they decreased by 0.2% compared to 2024, to 808.546 million packages.
The weighted average retail price of medicines at the end of 2025 was 210.65 UAH per package, which is 13% higher than at the end of 2024.
The pharmaceutical company “Farmak” remains the leader in retail sales in 2025 among domestic companies, with sales of nearly 10.978 billion UAH. The top 5 also included the pharmaceutical company “Darnitsa” (7.473 billion UAH), “Kyiv Vitamin Plant” (KVZ, nearly 6.842 billion UAH), ‘Arterium’ (5.975 billion UAH), and “Pharma Star/Acino” (2.9 billion UAH).
Pharmacy sales in Ukraine in April 2025 decreased by 6.7% in monetary terms compared to March of this year, to UAH 16.96 billion, while in real terms they remained at 94.562 million packages, which is 0.41% more than in March.
According to information provided to the Interfax-Ukraine news agency by Business Credit, based on its research, the weighted average price of goods in the pharmacy basket at the end of April was 179.36 UAH, which is 7.1% less than in March.
At the same time, pharmacy sales of medicines in April 2025 amounted to more than UAH 13.071 billion, which is 8% less than in March. In real terms, pharmacy sales of medicines in April decreased by 2.15% compared to March, to 65.742 million packages.
The average retail price of medicines in April was 198.83 UAH per unit, which is 6.09 less than in March.
Pharmacy sales of dietary supplements in April decreased by 6.47% in monetary terms, to UAH 1.952 billion, and by almost 1.74% in real terms, to 8.368 million packages. The average price in this segment at the end of April decreased by 4.82% compared to March, to UAH 232.82 per unit.
At the same time, according to Business Credit, in April, the pharmacy segment saw price increases compared to March for dermatological cosmetics (by 11.9%), cosmetics (by 5.54%), and medical equipment (by 5.74%).
As reported, pharmacy sales in Ukraine at the end of 2024 increased in monetary terms by 10.67% compared to 2023, to UAH 192.843 billion, and in real terms decreased by 5%, to over 1.157 billion packages. The average price of goods in the pharmacy basket at the end of 2024 was UAH 166.59, which is 16.53% more than in 2023.
At the same time, pharmacy sales of medicines in 2024 amounted to UAH 151 billion, which is 10.83% more than a year earlier, but in real terms, pharmacy sales of medicines decreased by 5.64% to 810.155 million packages. The weighted average retail price of medicines at the end of 2024 was UAH 186.39 per unit, which is 17.45% more than in 2023.
Pharmacy sales of dietary supplements in 2024 increased by 11.06% in monetary terms, to UAH 19.992 billion, and decreased by almost 3.06% in real terms, to 99.012 million packages. The weighted average price in this segment at the end of 2024 increased by 14.56% compared to 2023, to UAH 201.92 per unit.
According to the Ministry of Health, as of the end of April, there has been a significant decrease in prices for medicines included in the list of the top 100 most popular medicines and in the additional list of 200 medicines. The retail prices of medicines from the additional list (over 200 Ukrainian medicines) fell by 30%.
In February, Ukrainian President Volodymyr Zelensky enacted the National Security and Defense Council’s decision of February 12 on additional measures to ensure the availability of medicines for Ukrainians. According to this decision, the government, manufacturers, and pharmacy chains will determine a list of 100 drugs for which prices will be reduced by 30% starting March 1. It was also planned to ban marketing and promotional services related to the sale of medicines to end consumers from March 1 until the Cabinet of Ministers introduces separate wholesale price references for all medicines.
